Clinical Trial Update: Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy, tolerability, and safety of intranasal granisetron for preventing chemotherapy-induced nausea and vomiting. Results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Granisetron (granisetron)

Snippet

Sponsor: Shin Nippon Biomedical Laboratories, Ltd. | Conditions: Chemotherapy-Induced Nausea and Vomiting | Phase 2 | Status: COMPLETED | Results posted: 2011-06-21